Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA
EClinicalMedicine
- GLP-1 receptor agonists
- Semaglutide
- GLP-1 and incretin signalling
- Resistant hypertension
- Overweight
- Humans
The paper
Tian Z, Willerding JM, Schmidt-Ott KM et al.
EClinicalMedicine · 29 Aug 2026
